PA550585

RARRES1 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PA550585-Each-of-1 In Stock ₹ 46,502.50

PA550585 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

RARRES1

Classification

Polyclonal

Conjugate

Unconjugated

Gene

RARRES1

Gene Alias

5430417P09Rik; AI662122; latexin-like; LXNL; PEIG1; PERG-1; phorbol ester-induced gene 1 protein; Rarres1; RAR-responsive protein TIG1; retinoic acid receptor responder (tazarotene induced) 1; retinoic acid receptor responder 1; retinoic acid receptor responder protein 1; Tazarotene-induced gene 1 protein; tazarotene-induced protein 1; TIG1

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

5918

Content And Storage

-20°C

Form

Liquid

Applications

Immunohistochemistry (Paraffin), Western Blot

Concentration

2.2 mg/mL

Formulation

PBS with 40% glycerol and 0.05% sodium azide; pH 7.4

Gene Accession No.

P49788

Gene Symbols

RARRES1

Immunogen

Synthetic peptide corresponding to a region derived from internal residues of human Retinoic acid receptor responder (tazarotene induced) 1

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PA550708

--

Img

Thermo Scientific

PA550851

--

Img

Thermo Scientific

PA550505

--

Img

Thermo Scientific

PA550575

--

Img

Thermo Scientific

PA550233

--

Img

Thermo Scientific

PA550225

--

Img

Thermo Scientific

PA550672

--

Img

Thermo Scientific

PA550442

--

Description

  • The antibody detects endogenous levels of total TIG1 protein
  • This gene was identified as a retinoid acid (RA) receptor-responsive gene
  • It encodes a type 1 membrane protein
  • The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors
  • The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island
  • Alternatively spliced transcript variant encoding distinct isoforms have been observed.